Cybrexa Therapeutics
Cybrexa Therapeutics is a small Molecule DNA repair Inhibitors founded in 2017.
4
Funding Rounds
$50.4m
Money raised
Funding
Funding series
Funding Series Analysis
The company Cybrexa Therapeutics has raised a total of $44.4m in funding over 4 rounds.
Key Insights:
- Cybrexa Therapeutics Series B round, March 2021: $25m
- Cybrexa Therapeutics , June 2019: $13.4m
- Cybrexa Therapeutics Series B round, June 2017: $6m
- Cybrexa funding round, June 2017: $6m
Cybrexa Therapeutics Series B round, March 2021
$25m
Cybrexa Therapeutics , June 2019
$13.4m
Cybrexa Therapeutics Series B round, June 2017
$6m
Cybrexa funding round, June 2017
$6m
Industries
Cybrexa Therapeutics is active in the following industries: